| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.98B | 57.08B | 55.72B | 53.91B | 55.07B | 64.20B |
| Gross Profit | 16.52B | 15.97B | 15.95B | 15.27B | 17.67B | 25.98B |
| EBITDA | 4.86B | 4.61B | 4.95B | 4.89B | 6.85B | 7.49B |
| Net Income | 1.13B | 951.00M | 1.11B | 1.41B | 2.12B | 3.40B |
Balance Sheet | ||||||
| Total Assets | 78.77B | 80.20B | 81.28B | 79.37B | 80.60B | 85.92B |
| Cash, Cash Equivalents and Short-Term Investments | 10.84B | 11.69B | 11.34B | 13.28B | 12.78B | 13.87B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 10.31B | 11.61B | 12.26B | 10.86B | 10.96B | 15.01B |
| Stockholders Equity | 68.46B | 68.60B | 69.02B | 68.51B | 69.63B | 70.91B |
Cash Flow | ||||||
| Free Cash Flow | 694.00M | 1.37B | 778.00M | 1.92B | 179.00M | -58.00M |
| Operating Cash Flow | 1.46B | 4.49B | 2.80B | 3.33B | 5.10B | 6.11B |
| Investing Cash Flow | -841.50M | -2.82B | -3.42B | -168.00M | -3.33B | -5.60B |
| Financing Cash Flow | -328.00M | -1.31B | -1.31B | -2.67B | -2.87B | -1.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥1.27T | 18.60 | 11.19% | 1.46% | 2.65% | -5.76% | |
71 Outperform | ¥563.39B | 19.60 | 9.28% | 1.30% | 5.50% | 27.32% | |
68 Neutral | ¥23.43B | 4.38 | ― | 1.87% | 3.08% | -16.77% | |
62 Neutral | ¥23.94B | 23.77 | ― | 2.05% | 0.99% | 830.67% | |
61 Neutral | ¥4.06T | 20.92 | 9.46% | 1.32% | 1.99% | -18.79% | |
57 Neutral | $3.13B | 9.23 | -34.32% | 3.14% | -25.56% | -353.61% | |
56 Neutral | ¥47.34B | 18.12 | 1.97% | 2.92% | 0.82% | 46.96% |